Clinical Utility of Gallium-68 PSMA PET/CT Scan for Prostate Cancer. - Wikidata - wikimedia - TriplyDB

Clinical Utility of Gallium-68 PSMA PET/CT Scan for Prostate Cancer.

Clinical Utility of Gallium-68 PSMA PET/CT Scan for Prostate Cancer.

http://www.wikidata.org/entity/Q33711641

about

Nonspecific Uptake of Ga-Prostate-Specific Membrane Antigen in Diseases other than Prostate Malignancy on Positron Emission Tomography/Computed Tomography Imaging: A Pictorial Assay and Review of Literature

P2860

Q58593270-A229A392-7736-4F80-A676-4CC6D0886804

P2860

Clinical Utility of Gallium-68 PSMA PET/CT Scan for Prostate Cancer.

http://www.wikidata.org/entity/Q33711641

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Clinical Utility of Gallium-68 PSMA PET/CT Scan for Prostate Cancer.

@ast

Clinical Utility of Gallium-68 PSMA PET/CT Scan for Prostate Cancer.

@en

type

label

Clinical Utility of Gallium-68 PSMA PET/CT Scan for Prostate Cancer.

@ast

Clinical Utility of Gallium-68 PSMA PET/CT Scan for Prostate Cancer.

@en

prefLabel

Clinical Utility of Gallium-68 PSMA PET/CT Scan for Prostate Cancer.

@ast

Clinical Utility of Gallium-68 PSMA PET/CT Scan for Prostate Cancer.

@en

P1433

Q33711641-8DFFCB7E-3E12-44F8-87F9-FBD6EB6AF7C8

P1476

Q33711641-90ADAF68-C78F-4BB5-8E3A-14DAE7BDAD1B

P2093

Q33711641-270FF2A3-54D8-4D48-8A07-111A666FB02A

Q33711641-3AA6E683-BA3C-4B38-A03C-E597D7033220

Q33711641-3EDA8831-589F-407E-9F6A-3D070929129A

Q33711641-45B58CAD-CB38-4FA4-9834-643DEB30257A

Q33711641-4EF2ADE2-A279-4891-8325-DB322D88C2C4

Q33711641-555B2D58-B0CD-48CB-B986-AC523A992FCF

Q33711641-5D9D4FCA-A8EC-471B-A6D1-ED388C0A9D4A

Q33711641-7BA1AB10-3A38-4608-BAD0-A331409A3398

Q33711641-7ED5CC17-4405-4696-A50F-5E5F4DCA9697

Q33711641-970AB329-5145-433E-A3D1-DA52F51661F1

P2860

Q33711641-009881E7-38C1-4C79-AA7A-9A14B2A9F22C

Q33711641-13BF631E-6E5F-4B85-B8FB-8AD48D30298E

Q33711641-1A50C93C-49C0-419D-B770-36EBF2393F6D

Q33711641-1C8C5D28-2CA1-4816-AFDC-E9648CDFCA4F

Q33711641-1CD7ECD3-B165-4082-B82D-1F30931FE88C

Q33711641-1FF102F6-BA68-4E3F-BCCC-AE818171CEA6

Q33711641-2ACF3C49-10C8-4BFB-A0A0-AB1B37480AA1

Q33711641-2C6A5A73-7F5D-4C9D-9636-D0095A27E2AF

Q33711641-3CBCBDCF-8C77-4181-B565-445AEF12260F

Q33711641-47D386E1-221C-4200-932D-46608C3B763B

P304

Q33711641-75919C51-797E-4767-9045-5BDF70679467

P31

Q33711641-0370FC8B-47EB-40F7-9F16-23F4B8136405

P356

Q33711641-3F51814D-EC9A-407A-A43D-F88598896EBE

P433

Q33711641-9334CF62-B713-4EE0-A684-23F82C30E2AA

P478

Q33711641-CD16A881-D247-4FE1-A6A3-2D25E86CCC02

P577

Q33711641-86598F5D-D842-498E-9A85-190B65FC0BF9

P698

Q33711641-EDD7BD8C-7273-4ADC-9E61-3A84F47507DE

P932

Q33711641-DC16390E-186B-4FAE-8548-95731D6DA7BB

P356

0972-3919.202255

P1433

Indian Journal of Nuclear Medicine

P1476

Clinical Utility of Gallium-68 PSMA PET/CT Scan for Prostate Cancer.

@en

P2093

Basavalingaiah S Ajaikumar

http://www.w3.org/2001/XMLSchema#string

Hemantha M Kumara

http://www.w3.org/2001/XMLSchema#string

Indiresh Desai

http://www.w3.org/2001/XMLSchema#string

Krishnappa Rajkumar

http://www.w3.org/2001/XMLSchema#string

Kumaraswamy G Kallur

http://www.w3.org/2001/XMLSchema#string

Nagaraj Madhusudhan

http://www.w3.org/2001/XMLSchema#string

P S Sridhar

http://www.w3.org/2001/XMLSchema#string

Prashanth G Ramachandra

http://www.w3.org/2001/XMLSchema#string

Raghavendra M Rao

http://www.w3.org/2001/XMLSchema#string

Raghunath S Krishnappa

http://www.w3.org/2001/XMLSchema#string

P2860

Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer

Constitutive and antibody-induced internalization of prostate-specific membrane antigen.

Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.

National Comprehensive Cancer Network guidelines for the management of prostate cancer.

Comparative performance of PET tracers in biochemical recurrence of prostate cancer: a critical analysis of literature.

Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.

Technical considerations when obtaining and interpreting prostatic biopsies from men with suspicion of early prostate cancer: part I.

Biological variation of total prostate-specific antigen: a survey of published estimates and consequences for clinical practice.

Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer.

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.

P304

110-117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0972-3919.202255

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28533638

http://www.w3.org/2001/XMLSchema#string

P932

5439210

http://www.w3.org/2001/XMLSchema#string